Go back to Resource Center
Palivizumab prophylaxis of RSV disease: demographic and risk factors results from the 2002-2003 Outcomes Registry
2003
Journal Article
Authors:
Hudak, M.;
Boron, M.;
Cohen, A.;
Van Veldhuisen, P.;
Group, thePalivizuma
Location: New Orleans, LA
Go back to Resource Center
